Target
Mu-type opioid receptor
Ligand
BDBM50535159
Substrate
n/a
Meas. Tech.
ChEMBL_1929931 (CHEMBL4433107)
Ki
0.400000±n/a nM
Citation
 Rosse, G Treatment of Pain with Spirocylic Cyclohexane Derivatives Having Dual Specificity for ORL-1 and ?-Opioid Receptors. ACS Med Chem Lett 7:822-3 (2016) [PubMed]  Article 
Target
Name:
Mu-type opioid receptor
Synonyms:
M-OR-1 | MOP | MOR-1 | MOR1 | MUOR1 | Mu Opioid Receptor | Mu opiate receptor | OPIATE Mu | OPRM1 | OPRM_HUMAN | hMOP | mu-type opioid receptor isoform MOR-1
Type:
G Protein-Coupled Receptor (GPCR)
Mol. Mass.:
44789.51
Organism:
Homo sapiens (Human)
Description:
P35372
Residue:
400
Sequence:
MDSSAAPTNASNCTDALAYSSCSPAPSPGSWVNLSHLDGNLSDPCGPNRTDLGGRDSLCPPTGSPSMITAITIMALYSIVCVVGLFGNFLVMYVIVRYTKMKTATNIYIFNLALADALATSTLPFQSVNYLMGTWPFGTILCKIVISIDYYNMFTSIFTLCTMSVDRYIAVCHPVKALDFRTPRNAKIINVCNWILSSAIGLPVMFMATTKYRQGSIDCTLTFSHPTWYWENLLKICVFIFAFIMPVLIITVCYGLMILRLKSVRMLSGSKEKDRNLRRITRMVLVVVAVFIVCWTPIHIYVIIKALVTIPETTFQTVSWHFCIALGYTNSCLNPVLYAFLDENFKRCFREFCIPTSSNIEQQNSTRIRQNTRDHPSTANTVDRTNHQLENLEAETAPLP
  
Inhibitor
Name:
BDBM50535159
Synonyms:
CHEMBL4466096
Type:
Small organic molecule
Emp. Form.:
C22H34N2O2S
Mol. Mass.:
390.583
SMILES:
COC1(CCN2CC3(CC2=O)CCC(CC3)(N(C)C)c2cccs2)CCC1 |(60.45,-7.81,;61.6,-6.79,;63.06,-7.29,;64.22,-6.27,;65.68,-6.76,;66.83,-5.74,;68.35,-6.07,;69.13,-4.74,;68.11,-3.58,;66.69,-4.19,;65.36,-3.41,;69.9,-6.07,;71.42,-6.07,;72.2,-4.75,;71.43,-3.42,;69.9,-3.41,;73.28,-3.65,;74.77,-4.04,;72.87,-2.16,;73.28,-5.83,;74.8,-5.59,;75.49,-6.96,;74.41,-8.04,;73.04,-7.35,;62.28,-8.62,;63.61,-9.4,;64.39,-8.07,)|
Structure:
Search PDB for entries with ligand similarity: